Queensbury, N.Y.-based Delcath (NSDQ:DCTH) announced last week that it plans to pare its workforce by about 20%, the latest in a series of layoff announcements from the oncology devices maker. This is the 3rd time this year that Delcath has announced imminent layoffs, having announced smaller cuts in April and larger layoffs in January.
The FDA granted 510(k) clearance to the system but has yet to formally announce the decision, according to the watchdog agency’s website.
NURO shares surged as much as 22% this morning on the news and were up 10.8% to 72¢ as of about 10:20 a.m.
The Chinese medical device market may triple by 2018, partially due to high rates of tobacco consumption and a rapidly growing economy, according to a market report.